10/12/2026
Join us for the ASPS Ventures Panel and Happy Hour at Plastic Surgery The Meeting! The ASPS innovation ecosystem supports surgeon innovators at every stage, and each panelist brings the view from a different one. Stay after to connect over drinks.
π‘ The idea. Justin Sacks, MD, MBA, turned a problem he saw in the OR into TissueLock, first pitched at the ASPS Inventors Challenge and now in the 2026 MTI/ASPS Accelerator cohort.
π The investment. Bill Perry, CIO of ASPS Ventures and co-founder and CEO of Deep Blue Medical Advances, has spent nearly three decades building medtech companies and knows what it takes to back one.
π The company. Tom Roueche leads Fesarius Therapeutics, a commercial-stage dermal repair company and the first ASPS Ventures investment. Fesarius went through the ASPS Ventures process before closing an oversubscribed $20M Series A, and shows what it looks like when surgeon insight and the right capital come together.
π§ The guidance. Lynn Jeffers, MD, MBA, FACS, Howie Levinson, MD, FACS, and Steven Williams, MD, bring deep expertise in medtech, investment and clinical practice. As ASPS Ventures board members, they help keep every stage grounded in what surgeons and patients need.
π Houston | Oct. 17, 2026
Wherever your idea is today, there's a place for it here.